Longato et al.
Table 1. Crystallographic Data and Details of Structural Refinement
Parameters for 2, 4, and 5
had the composition 2‚0.75H2O whereas the elemental analysis was
more consistent with the formulation 2‚3H2O. Anal. Calcd for
C32H32N6O3P2Pt‚H2O: C, 46.66; H, 4.16; N, 10.20. Found: C,
46.84; H, 4.02; N, 9.95. 31P NMR (121.5 MHz, in CD3CN): δ
2‚0.75H2O
4‚0.5CH2Cl2
5‚2DMF
formula
C96H97.5N18-
C26.50H27ClN2-
O6P2Pt
761.98
monoclinic
P21/c
10.947(3)
13.230(4)
21.344(5)
C64H72N10-
O11P4Pt2
1671.38
triclinic
P1h
13.805(4)
14.515(4)
20.672(5)
76.72(2)
75.59(3)
65.96(3)
3625.1(17)
2
2
-8.50 (1JPPt 3192 Hz), -9.34 (1JPPt 3372 Hz) with JPP 23.3 Hz.
O9.75P6Pt3
1H NMR (400.13 MHz, in CDCl3): δ major component (ca. 90%)
8.27 (s, 1H, H(8)), 7.65 (s, 1H, H(2)), 8.2-6.4 (m, 20 H, Ph), 7.11
(br s, 1H, NH), 3.45 (s, 3H, NMe), 2.75 (d, 2JHP 11.4 Hz, 3H, PMe),
fw
2430.51
monoclinic
P21/n
30.144(6)
18.216(4)
36.300(6)
crystal system
space group
a, Å
b, Å
c, Å
R, deg
â, deg
γ, deg
V, Å3
2
1.20 (d, JHP 10.3 Hz, 3H, PMe); minor component 8.14 (s, 1H,
H(2)), 6.82 (s, 1H, H(8)), 8.2-6.4 (m, 20 H, Ph), 5.8 (br s, 1H,
NH), 3.73 (s, 3 H, NMe), 2.33 (d, 2JHP 10 Hz, 3H, PMe), 1.83 (d,
2JHP 10 Hz, 3H, PMe). 13C NMR (100.61 MHz, in CDCl3): δ 166.2
(C-6), 155.8 (C-2), 154.5 (C-4), 141.8 (C-8), 128.3 (C-5), 30.2
(NCH3), 16.2 and 13.3 (PCH3).
1H NMR (400.13 MHz, in DMSO-d6): δ major component (ca.
60%) 8.04 (s, 1H, H(8)), 6.52 (s, 1H, H(2)), 5.25 (br s, 1H, NH),
3.56 (s, 3H, NMe), 2.23 (d, 2JHP 10 Hz, 3H, PMe), 2.12 (d, 2JHP 10
Hz, 3H, PMe). 13C NMR (100.61 MHz, in DMSO-d6): δ 164.9
(C-6), 157.8 (C-2), 147.5 (C-4), 140.1 (C-8), 128.3 (C-5), 30.6
(NCH3), 13.2 and 12.1 (PCH3).
93.58(4)
90.11(2)
19893(7)
8
1.623
7.003
9612
3091.2(15)
4
1.637
4.769
1492
Z
D
calcd, g cm-3
1.531
4.004
1660
µ, mm-1
F(000)
θ range, deg
reflns collected
reflns unique
reflns I > 2σ(I)
no. of params
R(int)
2.50-33.13
47103
25026
20185
1285
0.0549
1.021
0.0746
0.2081
2.154, -1.191
2.45-27.10
11190
6149
4654
346
0.0507
1.053
0.0492
0.1424
1.085, -0.888
1.79-27.88
28765
15805
10820
800
0.0519
1.054
0.0553
0.1578
1.300, -2.576
With the same procedure, complex 2 was obtained operating in
CH2Cl2 (isolated product 276 mg, yield 77%) and DMF (160 mg,
yield 88%).
GOF on F2
R1a
wR2a
cis-[(PMePh2)2Pt(ONO2)2] (4). A solution of AgNO3 (0.52 g,
3.06 mmol) in EtOH (8 mL) and H2O (1.5 mL) was slowly added
to a CH2Cl2 (13 mL) solution of cis-[(PMePh2)2PtCl2] (1.02 g, 1.53
mmol). The resulting precipitate was eliminated by filtration and
the solvent evaporated to dryness under vacuum, yielding 1.05 g
of product (yield 95%). The isolated solid contained small amounts
residuals, e‚Å-3
a R1 ) ∑||Fo| - |Fc||/∑|Fo|, wR2 ) [∑w(Fo - Fc )2/∑w(Fo )2]1/2
.
2
2
2
13C NMR (100.61 MHz, in CDCl3): δ 153.3 (C-2), 152.2 (C-6),
147.8 (C-8), 146.6 (C-4), 115.5 (C-5), 30.9 (NCH3), 13.1, 12.4,
and 9.5 (PCH3).
1
of CH2Cl2, seen by H NMR. Anal. Calcd for C26H26N2O6P2Pt‚
0.5CH2Cl2: C, 41.77; H, 3.57; N, 3.68. Found: C, 41.72; H, 3.42;
cis-[(PMePh2)2Pt(9-MeAd)2](NO3)2 (8). 9-MeAd (57 mg, 0.4
mmol) was added to a solution of 4 (137 mg, 0.2 mmol) in CH3-
CN (7 mL) and stirred for 1 h. The resulting solution, left at ambient
temperature for 5 days, separated a white solid, which was recovered
by filtration, washed with Et2O, and dried under vacuum. The yield
of 8 was 170 mg (88%). Anal. Calcd for C38H40N12O6P2Pt: C,
44.84; H, 3.96; N, 16.51. Found: C, 44.71; H, 3.92; N, 16.46. The
solid, insoluble in chlorinated solvents, was characterized in DMSO.
1H NMR (400.13, in DMSO-d6): δ major conformer (ca. 55%)
8.95 (s, 2H, H(2)), 8.6 (br s, 4H, NH2), 8.12 (s, 2H, H(8)), 7.7-
N, 3.44. 1H NMR (300 MHz, in DMSO-d6): δ 7.64-7.43 (m, 20H,
2
Ph), 2.02 (d, JHP 10.6 Hz, 6H, PMe). 31P NMR (121.5 MHz, in
1
DMSO-d6): δ -6.90 (s, JPPt 3903 Hz).
cis-[(PMePh2)2Pt(ONO2){9-MeAd(-H)}Pt(PMePh2)2]-
(NO3)2 (5). To a solution of 2 (135 mg, 0.056 mmol) in DMF (5
mL) was added 4 (121 mg, 0.168 mmol), and the resulting solution
was stirred at room temperature for 2 h. Addition of Et2O gave a
white solid, which was filtered, washed with Et2O, and dried under
vacuum. Crystallization of the crude product, by dissolution in DMF
and vapor diffusion of Et2O, afforded X-ray quality crystals of 5
(192 mg, yield 68%) having the formula cis-[(PMePh2)2Pt(ONO2)-
{9-MeAd(-H)}Pt(PMePh2)2](NO3)2‚2DMF (5‚2DMF). Anal. Calcd
for C64H72N10O11P4Pt2 (1671.4): C, 45.99; H, 4.34; N, 8.38.
2
6.8 (m, 20 H, Ph), 3.60 (s, 6H, NMe), 2.32 (d, JHP 11 Hz, 6H,
PMe); minor conformer (45%) 8.71 (s, 2H, H(2)), 8.6 (br s, 4H,
NH2), 8.11 (s, 2H, H(8)), 7.7-6.8 (m, 20 H, Ph), 3.57 (s, 6H, NMe),
2.32 (d, 2JHP 11 Hz, 6H, PMe). 13C NMR (100.61 MHz, in DMSO-
d6): δ more abundant conformer 155.0 (C-6), 152.1 (C-2), 148.8
(C-4), 144.8 (C-8), 120.5 (C-5), 29.6 (NCH3), 10.8 (PCH3); less
abundant conformer 154.4 (C-6), 153.1 (C-2), 148.7 (C-4), 144.8
(C-8), 120.7 (C-5), 29.6 (NCH3), 10.8 (PCH3).
1
Found: C, 45.69; H, 4.35; N, 8.64. H NMR (400.13, in DMSO-
d6): δ 8.64 (s, 1H, H(2)), 7.8-7.2 (m, 40 H, Ph), 6.52 (s, 1H,
H(8)), 5.30 (br s, 1H, NH), 3.56 (s, 3H, NMe), 2.50 (s, 6H, PMe),
2.26 (d, 2JHP 11.1 Hz, 3H, PMe), 1.97 (d, 2JHP 11.1 Hz, 3H, PMe);
DMF resonances at 7.9(s), 2.89 (s), and 2.73 (s). 13C NMR (100.6
MHz, in DMSO-d6): δ 164.9 (C-6), 157.8 (C-2), 147.5 (C-4), 140.1
(C-8), 124.9 (C-5), 30.6 (NCH3), 13.2 and 12.1 (PCH3).
X-ray Structure Determinations. Crystal data, data collection,
and refinement parameters for compounds 2, 4, and 5 are sum-
marized in Table 1. Due to the small crystal dimensions (ap-
proximately 0.15 × 0.14 × 0.10 mm), data collection of 2 was
carried out at the X-ray diffraction beamline of the Synchrotron
Elettra, Trieste, Italy, using a monochromatized wavelength of 1.000
Å. A total of 60 frames were collected on a 165 mm CCD
MarResearch (rotation of 3° about æ, fixed dose of radiation,
detector at 35 mm from the crystal, T ) 100(2) K). Data collections
of 4 and 5 were performed on a Nonius DIP-1030H system
equipped with Mo-KR radiation (λ ) 0.71073 Å) graphite-
monochromatized (30 frames, exposure time of 20 min, rotation
of 6° about æ, detector at 80 mm from the crystal, T ) 293(2) K).
Cell refinement, indexing, and scaling of all the data sets were
cis-[{(PMePh2)2Pt(ONO2)}2(9-MeAd)](NO3)2 (6). 9-MeAd (18.8
mg, 0.13 mmol) was added to a suspension of 4 (182 mg, 0.25
mmol) in CHCl3 (8 mL) and stirred at ambient temperature for 1
h. Addition of Et2O to the resulting solution afforded a white solid,
which was recovered by filtration, washed several times with Et2O,
and dried under vacuum. The yield of 6 was 160 mg (80%). Anal.
Calcd for C58H59N9O12P4Pt2 (1588.2): C, 43.86; H, 3.74; N, 7.94.
1
Found: C, 43.35; H, 3.44; N, 7.87. H NMR (400.13, in CDCl3)
δ: 11.08 (br s, 1H, NH2), 9.94 (s, 1H, H(8), 8.53 (br s, 1H, NH2),
8.01 (s, 1H, H(2)), 8.0-6.9 (m, 40 H, Ph), 3.52 (s, 3H, NMe),
2.39 (d, 2JHP 11.6 Hz, 3H, PMe), 2.26 (d, 2JHP 11.3 Hz, 3H, PMe),
2.13 (d, 2JHP 11.3 Hz, 3H, PMe), 1.96 (d, 2JHP 11.4 Hz, 3H, PMe).
7864 Inorganic Chemistry, Vol. 42, No. 24, 2003